🧠 AI-Powered Early Detection of Alzheimer’s
🌟 Inspiration
Growing up, I watched my grandmother struggle with dementia, and later Alzheimer’s disease. As a child, I didn’t fully understand what was happening, but I could see the toll it took on her—and on my family. The gradual loss of memory, the confusion, and the helplessness we felt as loved ones left a lasting mark on me. Those moments shaped my perspective on how devastating neurodegenerative diseases can be, not just for patients but for entire families.
Over time, I realized that one of the greatest challenges with Alzheimer’s is late diagnosis. By the time symptoms become obvious, opportunities for meaningful intervention are often limited. My grandmother’s journey made me determined to change that narrative—not just for my family, but for countless others facing similar struggles.
That determination inspired me to build something powerful: an AI-driven early detection tool that combines accuracy with interpretability. Unlike black-box models, this system provides transparent visual explanations clinicians can trust, ensuring that technology doesn’t replace human judgment but strengthens it. Most importantly, it is designed to run on low-resource devices, making it accessible in rural clinics and underserved communities where radiologists are scarce.
My vision is simple yet ambitious: to help families avoid the pain my own family endured. By enabling early detection, we can slow progression, improve care planning, and give patients and families more time—time to prepare, to connect, and to live with dignity. This project is not just about technology; it is about hope, equity, and impact.
⚙️ What it does
This tool classifies Alzheimer’s stages (0–3) from MRI brain scans using a deep learning model built with EfficientNet. It provides:
- Stage predictions with high accuracy
- Grad-CAM overlays to highlight brain regions influencing decisions
- SHAP visualizations for voxel-level feature attribution
- Confidence scores and entropy plots to assess prediction certainty
- Confusion matrix to evaluate classification performance
All outputs are designed to be clinically interpretable, supporting human-in-the-loop workflows.
🏗️ How we built it
- Data: Public Kaggle Alzheimer’s MRI datasets, structured into labeled DataFrames
- Model: EfficientNet with dynamic flattening for multi-label classification
- Training: Mixup augmentation, class weighting, early stopping, and adaptive learning rate scheduling
- Evaluation: Accuracy tracking, entropy-based uncertainty, and batch-level visualizations
- Interpretability: SHAP, Grad-CAM, confidence scores, and confusion matrix heatmaps
🚧 Challenges we ran into
- Class imbalance across Alzheimer’s stages required careful weighting and sampling
- Integrating interpretability tools like SHAP and Grad-CAM into EfficientNet architecture
- Deployment stability on Render with FastAPI backend
- Designing visual outputs that are both informative and intuitive for clinicians
🏆 Accomplishments that we're proud of
- Achieved 93.67% test accuracy on multi-stage classification
- Built a fully interpretable pipeline with SHAP, Grad-CAM, and entropy visualizations
- Created a reproducible, modular framework for medical imaging AI
- Designed visual dashboards that support clinical decision-making
- Positioned the project for *real-world deployment *
📚 What we learned
- How to balance performance with interpretability in medical AI
- Techniques for handling imbalanced data and optimizing training stability
- The importance of visual transparency in building clinician trust
- How to integrate SHAP and Grad-CAM into non-standard architectures
- Best practices for ethical deployment and open-source reproducibility
🚀 What's next for AI-Powered Early Detection of Alzheimer’s
- Expand to multimodal inputs: PET scans, cognitive scores, and genetic markers
- Integrate with mobile apps and EMR systems for real-time clinical use
- Launch pilot studies in rural clinics and public health networks
- Publish validation results in peer-reviewed journals
- Extend the pipeline to other neurodegenerative diseases (e.g., Parkinson’s, stroke)
- Build an open-source interpretability toolkit for medical AI transparency
Log in or sign up for Devpost to join the conversation.